Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mechanistic considerations in high-throughput screening

Robert A Copeland1

  • 1Department of Enzymology and Mechanistic Pharmacology, GlaxoSmithKline, 1250 South Collegeville Road, UP1345, Collegeville, PA 19426, USA. Robert.A.Copeland@gsk.com

Analytical Biochemistry
|August 5, 2003
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of Kinesin KIF18A Inhibitor ATX020: Tactical Application of Silicon Atom Replacement.

ACS medicinal chemistry letters·2025
Same author

Discovery of ATX968: An Orally Available Allosteric Inhibitor of DHX9.

Journal of medicinal chemistry·2025
Same author

Characterization of exoribonuclease XRN1 as a cancer target and identification of adenosine-3',5'-bisphosphate as a potent enzyme inhibitor.

Communications biology·2025
Same author

A Potent, Selective, Small-Molecule Inhibitor of DHX9 Abrogates Proliferation of Microsatellite Instable Cancers with Deficient Mismatch Repair.

Cancer research·2024
Same author

Development of assays to support identification and characterization of modulators of DExH-box helicase DHX9.

SLAS discovery : advancing life sciences R & D·2023
Same author

The importance of binding kinetics and drug-target residence time in pharmacology.

British journal of pharmacology·2023